SOFIA (Bulgaria), March 21 (SeeNews) - Sofia-listed producer of sanitary materials and drugs Medica expects a gross consolidated profit of 1.8 million levs ($1.4 million/917,000 euro) this year, up some 16%, thanks to staff training and introduction of new equipment, it said on Friday.
The company plans to invest 4.0 million levs in new equipment and launch of new products, Medica said in a filing with the Bulgarian Stock exchange. The company projects revenue growth of 11% to 14.9 million levs this year.
Medica is controlled by blue-chip Bulgarian drug maker Sopharma.
Shares in Medica were traded at 138 levs at 1100 GMT, unchanged from Thursday’s close.
(1 euro = 1.95583 Bulgarian levs)
Search for: exchange |
Search for: Bulgaria |
 | Research & Profiles SeeNews – Research & Profiles enables an access to over 4,000 comprehensive company and industry profiles and researches from 10 Southeast European countries. |
Terms & ConditionsPrivacyCopyrightPublished by All Data Processing. All rights reserved. Created by Ladger.
